Autologous stem cell transplantation in patients who object to a blood transfusion: Contribution of new pharmacological haematopoiesis support

British Journal of Haematology

Volumn 161, Issue 5, 2013, Pages 738-740

  Al Nawakil, Chadi ^a,b   Quarre, Marie Catherine ^a,b   Heshmati, Farhad ^a,b   Deau, Benedicte ^a,b   Park, Sophie ^a,b   Dreyfus, François ^a,b   Bouscary, Didier ^a,b   Tamburini, Jerome ^a,b  

^a Institut Cochin   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Jehovah's Witness; Nplate ; Thrombocytopenia; Transplantation

Indexed keywords

CARMUSTINE; CYTARABINE; ERYTHROPOIETIN; ETOPOSIDE; HEMOGLOBIN; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ROMIPLOSTIM;

ADULT; AGED; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD AUTOTRANSFUSION; CD34 SELECTION; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; FOLLOW UP; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; LETTER; MALE; MULTIPLE MYELOMA; NEUTROPENIA; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; BLOOD TRANSFUSION; FEASIBILITY STUDIES; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; JEHOVAH'S WITNESSES; MALE; MIDDLE AGED; NEOPLASMS; RELIGION AND MEDICINE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877838978     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12284     Document Type: Letter

References (9)

1. Ballen, K.K., Becker, P.S., Yeap, B.Y., Matthews, B., Henry, D.H. & Ford, P.A. (2004) Autologous stem-cell transplantation can be performed safely without the use of blood-product support. Journal of Clinical Oncology, 22, 4087-4094.
2. Brown, N.M., Matthews, B. & Ford, P.A. (2006) Treatment of a Jehovah's Witness using a transfusion-free autologous stem cell transplant protocol. Community Oncology, 3, 776-781.
3. George, J.N. (2010) Management of immune thrombocytopenia-something old, something new. New England Journal of Medicine, 363, 1959-1961.
4. Kuter, D.J., Rummel, M., Boccia, R., Macik, B.G., Pabinger, I., Selleslag, D., Rodeghiero, F., Chong, B.H., Wang, X. & Berger, D.P. (2010) Romiplostim or standard of care in patients with immune thrombocytopenia. New England Journal of Medicine, 363, 1889-1899.
5. Mohty, M., Duarte, R.F., Croockewit, S., Hubel, K., Kvalheim, G. & Russell, N. (2011) The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation. Leukemia, 25, 1-6.
6. Nurden, A.T., Viallard, J.F. & Nurden, P. (2009) New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. Lancet, 373, 1562-1569.
7. Samaras, P., Blickenstorfer, M., Siciliano, R.D., Haile, S.R., Buset, E.M., Petrausch, U., Mischo, A., Honegger, H., Schanz, U., Stussi, G., Stahel, R.A., Knuth, A., Stenner-Liewen, F. & Renner, C. (2011) Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim. Annals of Hematology, 90, 89-94.
8. Sloan, J.M. & Ballen, K. (2008) SCT in Jehovah's Witnesses: the bloodless transplant. Bone Marrow Transplantation, 41, 837-844.
9. Stasi, R., Bosworth, J., Rhodes, E., Shannon, M.S., Willis, F. & Gordon-Smith, E.C. (2010) Thrombopoietic agents. Blood Reviews, 24, 179-190.